Strata Skin Sciences, Inc.
SSKN
$2.59
-$0.03-1.15%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 6.87% | -30.39% | -16.48% | -93.18% | -95.17% |
| Total Depreciation and Amortization | -10.08% | -10.60% | -4.42% | -0.62% | 3.76% |
| Total Amortization of Deferred Charges | 5.71% | -10.46% | -22.56% | -19.25% | -10.83% |
| Total Other Non-Cash Items | -4.77% | 43.99% | 43.02% | 197.80% | 160.54% |
| Change in Net Operating Assets | 1,097.10% | 162.90% | -0.51% | 117.83% | 97.61% |
| Cash from Operations | 136.22% | 150.03% | -123.90% | 63.54% | 43.83% |
| Capital Expenditure | 67.40% | 43.00% | 54.66% | 18.50% | -34.34% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 67.40% | 43.00% | 54.66% | 18.50% | -14.93% |
| Total Debt Issued | -- | -100.00% | -100.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 87.05% | 97.18% | 77.20% | 68.60% | 72.20% |
| Cash from Financing | -71.94% | -69.74% | -101.89% | 1,468.60% | 1,472.20% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -63.95% | 80.29% | -1,096.66% | 135.40% | 122.85% |